Document is current
Any future updates will be listed below
-
Authors
Roberts, Roberta D. https://orcid.org/0009-0000-9420-0676
Chua, Winnie https://orcid.org/0000-0002-6747-8813
Khatibi, Ali https://orcid.org/0000-0003-0679-0499
Holmes, Nicholas P. https://orcid.org/0000-0001-9268-4179
Palles, Claire https://orcid.org/0000-0002-9670-2263
Kussaibati, Racha https://orcid.org/0000-0002-4836-7624
Wing, Alan M. https://orcid.org/0000-0002-2623-3801
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/R003971/1)
- License Information
-
More Information
Article History
Received: 10 November 2025
Accepted: 23 March 2026
First Online: 29 March 2026
Declarations
:
: The authors RDR, WC, AK, NPH, CP and AMW declare no competing interests. Author RK has received speaker honoraria from: Novartis, AstraZeneca, Roche, Bristol Myers Squibb, Lilly, Pfizer, Exact Sciences and Menarini Stemline.
: Informed consent was obtained from all individual participants included in the study.
